Recently, another clinical study from Korea tested for associations between glucose-lowering drugs and cancer metastasis in several cancer types; no associations were found, except for a weakly significant association between DPP-4 treatment and thyroid cancer metastasis (hazard ratio 3.89, confidence interval 1.04–9.64) [73]. Here, DPP4 is linked to cancer.